Golnaz Ebrahimi

TL;DR: While these rates may not reflect the true prevalence of drug resistance on a national scale, it does partially demonstrate some defects in the existing tuberculosis control program.

TL;DR: Patients with chronic pulmonary diseases who take steroids or immunomodulating therapy (eg, methotrexate, anti-tumor necrosis factor inhibitors), or who have concurrent sickle cell disease or other hemoglobinopathies, primary immunodeficiency disorders, human immunodficiency virus infection/acquired immunodeciciency syndrome, nephrotic syndrome, and hematologic or solid malignancies should be vaccinated with both 13-valent pneumococcal conj

TL;DR: The national hospital cost of NTM management is increasing and the results emphasize the importance of continued research in pulmonary NTM in order to improve current guidelines in prevention and treatment strategies.